In future research will be focus on the antitumor effect and novel pathways of PKRA7 (PROK2 antagonist) in human cervical cancer, and it may be important implications for the development of molecular target drug against human cervical cancer. This evidence concerns the gene PROK2 and cervical carcinoma.